Tsumura & Co
TSE:4540

Watchlist Manager
Tsumura & Co Logo
Tsumura & Co
TSE:4540
Watchlist
Price: 4 315 JPY -1.57% Market Closed
Market Cap: 331.2B JPY

P/E
Price to Earnings

12.1
Current
12.8
Median
20.8
Industry
Lower than median
Lower than industry value

Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.

P/E
12.1
=
Market Cap
327.7B JPY
/
Net Income
27.1B JPY
Market Cap P/E
JP
Tsumura & Co
TSE:4540
327.7B JPY 12.1
US
Eli Lilly and Co
NYSE:LLY
782.6B USD 73.9
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP -15 783.5
US
Johnson & Johnson
NYSE:JNJ
399.2B USD 28.4
DK
Novo Nordisk A/S
CSE:NOVO B
2.1T DKK 20.7
CH
Roche Holding AG
SIX:ROG
231.6B CHF 20.1
CH
Novartis AG
SIX:NOVN
198.1B CHF 18.8
UK
AstraZeneca PLC
LSE:AZN
174.5B GBP 32.1
US
Merck & Co Inc
NYSE:MRK
227.3B USD 13.3
IE
Endo International PLC
LSE:0Y5F
167.6B USD -57.3
US
Pfizer Inc
NYSE:PFE
143.6B USD 17.9
Earnings Growth PEG
JP
Tsumura & Co
TSE:4540
Average P/E: 26.3
12.1
28%
0.4
US
Eli Lilly and Co
NYSE:LLY
73.9
49%
1.5
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
28.4
26%
1.1
DK
Novo Nordisk A/S
CSE:NOVO B
20.7
19%
1.1
CH
Roche Holding AG
SIX:ROG
20.1
16%
1.3
CH
Novartis AG
SIX:NOVN
18.8
16%
1.2
UK
AstraZeneca PLC
LSE:AZN
32.1
36%
0.9
US
Merck & Co Inc
NYSE:MRK
13.3
18%
0.7
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -57.3 N/A N/A
US
Pfizer Inc
NYSE:PFE
17.9
29%
0.6

P/E Forward Multiples

Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/E
10
2-Years Forward
P/E
10.2
3-Years Forward
P/E
9.2